Edgewise Therapeutics Reports Q2 2025 Financials and Business
08 Aug 2025 //
PR NEWSWIRE
Edgewise Gets EMA Orphan Designation for Muscular Dystrophies Drug
23 Apr 2024 //
BUSINESSWIRE
Edgewise Positive 2-Year Becker Sevasemten Topline Data
15 Apr 2024 //
BUSINESSWIRE